Next Article in Journal
Development of Machine Learning Model to Predict the 5-Year Risk of Starting Biologic Agents in Patients with Inflammatory Bowel Disease (IBD): K-CDM Network Study
Next Article in Special Issue
Data Reproducibility and Effectiveness of Bronchodilators for Improving Physical Activity in COPD Patients
Previous Article in Journal
Daytime Neurophysiological Hyperarousal in Chronic Insomnia: A Study of qEEG
Previous Article in Special Issue
Comorbid Conditions in Chronic Obstructive Pulmonary Disease: Potential Therapeutic Targets for Unmet Needs
 
 
Review
Peer-Review Record

Diagnosis and Treatment of Early Chronic Obstructive Lung Disease (COPD)

J. Clin. Med. 2020, 9(11), 3426; https://doi.org/10.3390/jcm9113426
by Joon Young Choi 1 and Chin Kook Rhee 2,*
Reviewer 1:
Reviewer 2: Anonymous
J. Clin. Med. 2020, 9(11), 3426; https://doi.org/10.3390/jcm9113426
Submission received: 9 October 2020 / Revised: 23 October 2020 / Accepted: 23 October 2020 / Published: 26 October 2020

Round 1

Reviewer 1 Report

Well done review. Very good. 

 

As a minor comment: 

no sentences have been proposed on the relation of "early COPD" and different COPD phenotyping ie bronchiolity vs enphyisematous    

Author Response

Thank you for your valuable question. As you mentioned, there are various phenotype of COPD that may present different clinical manifestations. However, the concept of 'early COPD' has been proposed very recently, and there are lack of studies that focus on different phenotypes of early COPD. Further studies are needed on the basis of the new definition of 'early COPD', such as different lung function decline, annual exacerbation rates, overt symptoms depending on different phenotypes.

Reviewer 2 Report

The authors' review of the early COPD is complete and interesting.

I have some minor revisions to suggest concerning the two images.

Figure 1 :

- The symbols used to describe the curves "X" "O" are unclear

- FEV1 values are not reported in the vertical axis

- A more precise description in the legend of the figure is necessary

 

Figure 2 :

-I think it would be useful to indicate more clearly the beginning of the "CAT" arrow (Not applicable in Pre-COPD)

-It would be more useful to indicate an age scale in the horizontal axis or to eliminate the number "40"

- I would use a different color for the "Preclinical COPD" panel

- A more precise description in the legend of the figure is necessary

Author Response

Figure 1 :

- The symbols used to describe the curves "X" "O" are unclear

- FEV1 values are not reported in the vertical axis

- A more precise description in the legend of the figure is necessary

 

Answer)

- The symbols used to describe the curves has been changed (X -> No, O -> Yes)

- You have advised to describe exact FEV1 values in the vertical axis. However, figure 1 is a schematic graph that shows overall lung function decline according to early life disadvantages and tobacco exposures. Therefore it may be difficult to show exact FEV1 values in the vertical axis.

- We developed the figure legend as 'Lifelong lung function trajectories according to presence of early life disadvantages and tabacco exposures.'

 

Figure 2 :

-I think it would be useful to indicate more clearly the beginning of the "CAT" arrow (Not applicable in Pre-COPD)

-It would be more useful to indicate an age scale in the horizontal axis or to eliminate the number "40"

- I would use a different color for the "Preclinical COPD" panel

- A more precise description in the legend of the figure is necessary

 

Answer)

- We have changed the "CAT" arrow that shows not applicable in pre-COPD more clearly.

- We erased number "40" in the X- axis (Age).

- We changed the color of 'preclincal COPD' into purple.

- We changed the figure legend into "Definition of early COPD, pre-COPD and overt COPD'.

Back to TopTop